Appendix Cancer Clinical Trials

7 recruitingLast updated: June 17, 2026

There are 7 actively recruiting appendix cancer clinical trials across 4 countries. Studies span Not Applicable, Phase 1. Top locations include Amsterdam-Zuidoost, Netherlands, Cleveland, Ohio, United States, Ghent, East-Flanders, Belgium. Updated daily from ClinicalTrials.gov.


Appendix Cancer Trials at a Glance

7 actively recruiting trials for appendix cancer are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Amsterdam-Zuidoost, Cleveland, and Ghent. Lead sponsors running appendix cancer studies include Andreana Holowatyj, PhD, MSCI, Case Comprehensive Cancer Center, and Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Browse appendix cancer trials by phase

Treatments under study

About Appendix Cancer Clinical Trials

Looking for clinical trials for Appendix Cancer? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Appendix Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Appendix Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

Liver CancerEsophageal CancerColon Cancer+7 more
Case Comprehensive Cancer Center200 enrolled1 locationNCT06263088
Recruiting
Not Applicable

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Liver CancerBiliary Tract CancerColon Cancer+76 more
Cedars-Sinai Medical Center360 enrolled1 locationNCT04907643
Recruiting
Not Applicable

Target-specific immunoPET Imaging of Digestive System Carcinoma

MalignancyLiver CancerPancreatic Cancer+12 more
RenJi Hospital400 enrolled1 locationNCT06715839
Recruiting
Not Applicable

Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer

Colorectal, CancerEsophagus CancerSmall Bowel Cancer+2 more
Dartmouth-Hitchcock Medical Center36 enrolled1 locationNCT05780684
Recruiting
Phase 1

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

Colorectal, CancerPancreatic CancerGastric Cancer+5 more
University Hospital, Ghent45 enrolled1 locationNCT05277766
Recruiting

Genetics of Appendix Cancer Study

Appendiceal CancerAppendix CancerAppendiceal Adenocarcinoma+12 more
Andreana Holowatyj, PhD, MSCI700 enrolled1 locationNCT05734430
Recruiting

Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix

NeoplasmsAppendix Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1,000 enrolled1 locationNCT05919758